Acumen Pharmaceuticals, Inc. Share Price
Equities
ABOS
US00509G2093
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.235 USD | +2.05% | +2.48% | -16.47% |
04/04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
04/04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 190M 15.89B |
---|---|---|---|---|---|
Net income 2024 * | -68M -5.67B | Net income 2025 * | -93M -7.76B | EV / Sales 2024 * | - |
Net cash position 2024 * | 121M 10.08B | Net cash position 2025 * | 258M 21.49B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.6
x | P/E ratio 2025 * |
-2
x | Employees | 52 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.87% |
Latest transcript on Acumen Pharmaceuticals, Inc.
1 day | +1.74% | ||
1 week | +2.48% | ||
Current month | -20.80% | ||
1 month | -20.01% | ||
3 months | -6.21% | ||
6 months | +45.46% | ||
Current year | -16.47% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/06/01 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/06/01 |
Director/Board Member | 55 | 01/22/01 | |
Jeffrey Ives
BRD | Director/Board Member | 73 | 01/14/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 3.208 | +1.18% | 20 201 |
26/24/26 | 3.17 | -0.63% | 140,701 |
25/24/25 | 3.19 | +0.31% | 167,647 |
24/24/24 | 3.18 | +0.63% | 152,249 |
23/24/23 | 3.16 | +0.96% | 270,690 |
Delayed Quote Nasdaq, April 29, 2024 at 07:21 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.47% | 190M | |
+2.21% | 42.75B | |
+47.70% | 41.61B | |
+11.32% | 41.34B | |
-12.36% | 26.59B | |
+7.90% | 25.49B | |
-23.72% | 18.12B | |
+29.58% | 12.24B | |
-1.99% | 11.76B | |
+7.88% | 11B |
- Stock Market
- Equities
- ABOS Stock